Haleon PLC stock ticks up after earnings whiplash; here’s what matters for HLN shares

Haleon PLC shares edged up around 0.6% to 373.8 pence by 0924 GMT on Friday, after closing at 371.6 pence previously. The stock fluctuated between 371.1 and 373.8 pence during the session and has ranged from 274.4 to 419.5 pence over the last 52 weeks.

Haleon slipped 0.7% to 361.4 pence by 1218 GMT, with investors retreating from UK stocks amid fresh trade concerns.

Haleon shares edged higher in London on Tuesday after Goldman Sachs added the consumer-health group to its European Conviction List, a roster of the bank’s most differentiated buy ideas. The maker of Sensodyne toothpaste and Panadol and Advil painkillers was up 0.1% at 372.6 pence by 0959 GMT, within a 370.4p–373.8p session range; the stock has traded between 274.4p and 419.5p over the past year. In a note dated Monday, Goldman set a 12-month price target of 440 pence and said Haleon should benefit as U.S. inventory dynamics normalize and emerging-market penetration rises; it also added Bayer and removed AstraZeneca, among others. Investing.com